CV-2619 protects cultured astrocytes against reperfusion injury via nerve growth factor production

被引:19
作者
Takuma, K
Yoshida, T
Lee, E
Mori, K
Kishi, T
Baba, A
Matsuda, T
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Med Pharmacol, Suita, Osaka 5650871, Japan
[2] Kobe Gakuin Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Nishi Ku, Kobe, Hyogo 6512180, Japan
[3] Kobe Gakuin Univ, Fac Pharmaceut Sci, Dept Pharmacol, Nishi Ku, Kobe, Hyogo 6512180, Japan
[4] Kobe Gakuin Univ, Fac Pharmaceut Sci, Dept Biochem, Nishi Ku, Kobe, Hyogo 6512180, Japan
[5] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol Neuropharmacol, Suita, Osaka 5650871, Japan
关键词
CV-2619; NGF (nerve growth factor); astrocyte; apoptosis;
D O I
10.1016/S0014-2999(00)00701-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study, we examined the effect of the neuroprotective agent 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone (CV-2619) on reperfusion injury in cultured rat astrocytes after exposure to hydrogen peroxide (H2O2)-containing medium. CV-2619 (10 nM to 10 muM) significantly attenuated the reperfusion-induced decrease in cell viability. The compound showed an anti-apoptotic effect in this astrocyte injury model. Antioxidants such as ascorbic acid, alpha -tocopherol and reduced glutathione also inhibited H2O2 exposure-induced cytotoxicity. CV-2619 did not affect the levels of reactive oxygen species, but it increased nerve growth factor (NGF) production. The effect of CV-2619 on H2O2 exposure-induced cytotoxicity was blocked by cycloheximide and anti-NGF antibody. The protective effect of CV-2619 was antagonized by the mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase inhibitor 2'-amino-3'-methoxyflavone and the phosphatidylinositol-3 kinase inhibitor wortmannin. These findings suggest that the effect of CV-2619 is mediated at least partly by NGF production in astrocytes and that ERK and phosphatidylinositol-3 kinases play a role in the downstream mechanism. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:333 / 339
页数:7
相关论文
共 34 条
[1]   HYDROGEN-PEROXIDE MEDIATES AMYLOID-BETA PROTEIN TOXICITY [J].
BEHL, C ;
DAVIS, JB ;
LESLEY, R ;
SCHUBERT, D .
CELL, 1994, 77 (06) :817-827
[2]  
Bergamasco B, 1994, Funct Neurol, V9, P161
[3]   IDEBENONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN AGE-RELATED COGNITIVE DISORDERS [J].
GILLIS, JC ;
BENFIELD, P ;
MCTAVISH, D .
DRUGS & AGING, 1994, 5 (02) :133-152
[4]  
GNAHN H, 1983, DEV BRAIN RES, V9, P45, DOI 10.1016/0165-3806(83)90107-4
[5]  
HEFTI F, 1986, J NEUROSCI, V6, P2155
[6]   CHRONIC INTRAVENTRICULAR-INJECTIONS OF NERVE GROWTH-FACTOR ELEVATE HIPPOCAMPAL CHOLINE-ACETYLTRANSFERASE ACTIVITY IN ADULT-RATS WITH PARTIAL SEPTO-HIPPOCAMPAL LESIONS [J].
HEFTI, F ;
DRAVID, A ;
HARTIKKA, J .
BRAIN RESEARCH, 1984, 293 (02) :305-311
[7]   A MODEL FOR BETA-AMYLOID AGGREGATION AND NEUROTOXICITY BASED ON FREE-RADICAL GENERATION BY THE PEPTIDE - RELEVANCE TO ALZHEIMER-DISEASE [J].
HENSLEY, K ;
CARNEY, JM ;
MATTSON, MP ;
AKSENOVA, M ;
HARRIS, M ;
WU, JF ;
FLOYD, RA ;
BUTTERFIELD, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3270-3274
[8]   Idebenone protects hippocampal neurons against amyloid β-peptide-induced neurotoxicity in rat primary cultures [J].
Hirai, K ;
Hayako, H ;
Kato, K ;
Miyamoto, M .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (05) :582-585
[9]  
Liu XZ, 1997, J NEUROSCI, V17, P5395
[10]  
Matsuda T, 1998, J NEUROCHEM, V70, P2004